Notes to the SCC | O'Shaughnessy's

‘Treatment’ Providers Ponder MJ Legalization

Kevin Hill’s paper in JAMA March 14, “Cannabis Use and Risk for Substance Use...

The Diagnostic and Statistical Manual of the American Psychiatric Association is known as “The...

GW Pharmaceuticals, Insys, and other companies seeking FDA approval for cannabinoid drugs must...

Jodi Duke of CORE (Cannabis Outreach & Education Network) confirms that the March 11...

Thanks to Dr. Barth for sending this article from the December 2016 issue of “The Health...